Busser B - Search Results

1

Characterization of foreign materials in paraffin-embedded pathological specimens using in situ multi-elemental imaging with laser spectroscopy.

Busser B, Moncayo S, Trichard F, Bonneterre V, Pinel N, Pelascini F, Dugourd P, Coll JL, D'Incan M, Charles J, Motto-Ros V, Sancey L. Busser B, et al. Mod Pathol. 2018 Mar;31(3):378-384. doi: 10.1038/modpathol.2017.152. Epub 2017 Nov 17. Mod Pathol. 2018. PMID: 29148536 Free article.

2

Amphiregulin promotes BAX inhibition and resistance to gefitinib in non-small-cell lung cancers.

Busser B, Sancey L, Josserand V, Niang C, Favrot MC, Coll JL, Hurbin A. Busser B, et al. Mol Ther. 2010 Mar;18(3):528-35. doi: 10.1038/mt.2009.226. Epub 2009 Oct 13. Mol Ther. 2010. PMID: 19826406 Free PMC article.

3

Amphiregulin promotes resistance to gefitinib in nonsmall cell lung cancer cells by regulating Ku70 acetylation.

Busser B, Sancey L, Josserand V, Niang C, Khochbin S, Favrot MC, Coll JL, Hurbin A. Busser B, et al. Mol Ther. 2010 Mar;18(3):536-43. doi: 10.1038/mt.2009.227. Epub 2009 Oct 13. Mol Ther. 2010. PMID: 19826407 Free PMC article.

4

Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma.

Hurbin A, Wislez M, Busser B, Antoine M, Tenaud C, Rabbe N, Dufort S, de Fraipont F, Moro-Sibilot D, Cadranel J, Coll JL, Brambilla E. Hurbin A, et al. Among authors: busser b. J Pathol. 2011 Sep;225(1):83-95. doi: 10.1002/path.2897. Epub 2011 May 19. J Pathol. 2011. PMID: 21598249 Clinical Trial.

5

The multiple roles of amphiregulin in human cancer.

Busser B, Sancey L, Brambilla E, Coll JL, Hurbin A. Busser B, et al. Biochim Biophys Acta. 2011 Dec;1816(2):119-31. doi: 10.1016/j.bbcan.2011.05.003. Epub 2011 May 30. Biochim Biophys Acta. 2011. PMID: 21658434 Review.

6

Identification of a novel complex BRAF mutation associated with major clinical response to vemurafenib in a patient with metastatic melanoma.

Busser B, Leccia MT, Gras-Combe G, Bricault I, Templier I, Claeys A, Richard MJ, de Fraipont F, Charles J. Busser B, et al. JAMA Dermatol. 2013 Dec;149(12):1403-6. doi: 10.1001/jamadermatol.2013.8198. JAMA Dermatol. 2013. PMID: 24108467

7

The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism.

Jeannot V, Busser B, Brambilla E, Wislez M, Robin B, Cadranel J, Coll JL, Hurbin A. Jeannot V, et al. Among authors: busser b. Int J Cancer. 2014 Jun 1;134(11):2560-71. doi: 10.1002/ijc.28594. Epub 2013 Dec 13. Int J Cancer. 2014. PMID: 24374738

8

Major response to vemurafenib in patient with severe cutaneous Langerhans cell histiocytosis harboring BRAF V600E mutation.

Charles J, Beani JC, Fiandrino G, Busser B. Charles J, et al. Among authors: busser b. J Am Acad Dermatol. 2014 Sep;71(3):e97-9. doi: 10.1016/j.jaad.2014.03.038. J Am Acad Dermatol. 2014. PMID: 25128147 Free article. No abstract available.

9

Laser spectrometry for multi-elemental imaging of biological tissues.

Sancey L, Motto-Ros V, Busser B, Kotb S, Benoit JM, Piednoir A, Lux F, Tillement O, Panczer G, Yu J. Sancey L, et al. Among authors: busser b. Sci Rep. 2014 Aug 14;4:6065. doi: 10.1038/srep06065. Sci Rep. 2014. PMID: 25338518 Free PMC article.

10

A recombinant fungal lectin for labeling truncated glycans on human cancer cells.

Audfray A, Beldjoudi M, Breiman A, Hurbin A, Boos I, Unverzagt C, Bouras M, Lantuejoul S, Coll JL, Varrot A, Le Pendu J, Busser B, Imberty A. Audfray A, et al. Among authors: busser b. PLoS One. 2015 Jun 4;10(6):e0128190. doi: 10.1371/journal.pone.0128190. eCollection 2015. PLoS One. 2015. PMID: 26042789 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters